Dyne Therapeutics, Inc. DYN Non Cash Lease Expense
Non Cash Lease Expense at other companies
Other financials
Where this comes from
Reported directly by Dyne Therapeutics, Inc. in its filing.
Tagged under the XBRL concept dyn:NonCashLeaseExpense.
The official record: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dyne Therapeutics, Inc.'s non cash lease expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dyne Therapeutics, Inc.'s non cash lease expense?
- Dyne Therapeutics, Inc. (DYN) reported non cash lease expense of $116K in Q1 2026.
- How has Dyne Therapeutics, Inc.'s non cash lease expense changed year-over-year?
- Dyne Therapeutics, Inc.'s non cash lease expense increased by 54.7% year-over-year, from $75K to $116K.
- What is the long-term trend for Dyne Therapeutics, Inc.'s non cash lease expense?
- Over 2 years (2021 to 2024), Dyne Therapeutics, Inc.'s non cash lease expense has grown at a -12.6% compound annual growth rate (CAGR), from -$746K to $570K.
- What does non cash lease expense mean?
- This metric represents the portion of lease expenses recognized in the income statement that does not involve an immediate cash outflow, typically associated with the amortization of right-of-use assets. It is a non-cash adjustment used to reconcile net income to net cash provided by operating activities. Monitoring this helps investors understand the impact of lease accounting standards on reported earnings without affecting liquidity.